SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 68 filers reported holding SAVARA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $939,564 | +37.2% | 248,562 | +16.0% | 0.00% | – |
Q2 2023 | $684,848 | +1175.3% | 214,350 | +678.4% | 0.00% | – |
Q1 2023 | $53,701 | -19.2% | 27,539 | -35.8% | 0.00% | – |
Q4 2022 | $66,467 | -0.8% | 42,882 | 0.0% | 0.00% | – |
Q3 2022 | $67,000 | +1.5% | 42,882 | 0.0% | 0.00% | – |
Q2 2022 | $66,000 | +15.8% | 42,882 | 0.0% | 0.00% | – |
Q1 2022 | $57,000 | +5.6% | 42,882 | 0.0% | 0.00% | – |
Q4 2021 | $54,000 | -10.0% | 42,882 | 0.0% | 0.00% | – |
Q3 2021 | $60,000 | -17.8% | 42,882 | 0.0% | 0.00% | – |
Q2 2021 | $73,000 | -65.1% | 42,882 | -57.1% | 0.00% | – |
Q1 2021 | $209,000 | +65.9% | 100,055 | -8.0% | 0.00% | – |
Q4 2020 | $126,000 | +5.9% | 108,755 | 0.0% | 0.00% | – |
Q3 2020 | $119,000 | -56.1% | 108,755 | 0.0% | 0.00% | – |
Q2 2020 | $271,000 | +60.4% | 108,755 | +36.9% | 0.00% | – |
Q1 2020 | $169,000 | -51.7% | 79,437 | +1.8% | 0.00% | – |
Q4 2019 | $350,000 | +69.1% | 78,019 | 0.0% | 0.00% | – |
Q3 2019 | $207,000 | +11.9% | 78,019 | 0.0% | 0.00% | – |
Q2 2019 | $185,000 | -57.8% | 78,019 | +31.5% | 0.00% | – |
Q1 2019 | $438,000 | -5.8% | 59,311 | -3.2% | 0.00% | – |
Q4 2018 | $465,000 | -32.1% | 61,298 | 0.0% | 0.00% | – |
Q3 2018 | $685,000 | +12.7% | 61,298 | +14.2% | 0.00% | – |
Q2 2018 | $608,000 | – | 53,658 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |